Evidence map›Paper›PMID 41422188›Full record

Trial reportJournal of patient-reported outcomes2025

Quantitative assessment of visual designs for communicating patient-reported outcomes in breast cancer care to patients.

Lea Doppelbauer, Anna Maria Hage, Maria Margarete Karsten, Pimrapat Gebert, Anna Tatzber, Laura Hatzler, Jasper Brands, Rosanne Andriessen, Therese Pross

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of patient-reported outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lea DoppelbauerCharité Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0001-9539-6164
Anna Maria HageCharité Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0003-1612-8052
Maria Margarete KarstenCharité Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0001-7587-7550
Pimrapat GebertCharité Universitätsmedizin Berlin, Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-5946-7137
Anna TatzberCharité Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.
Laura HatzlerCharité Universitätsmedizin Berlin, Department of Urology, Institute of Sexology and Sexual Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0001-8795-6205
Jasper BrandsPanton bv, Muntengang 1, Deventer, 7411 GD, Netherlands.
Rosanne AndriessenPanton bv, Muntengang 1, Deventer, 7411 GD, Netherlands.
Therese ProssCharité Universitätsmedizin Berlin, Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117, Berlin, Germany. therese.pross@charite.de.ORCID http://orcid.org/0000-0002-9942-4182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient-reported outcomes (PROs) are increasingly recognized as valuable data to enhance communication and support shared decision-making in cancer care. Despite evidence of their positive effects, few concrete approaches exist for the design and presentation of PRO visualizations. Even in high-incidence cancers such as breast cancer, limited knowledge is available on how patients perceive and interpret graphical displays of PRO results. This study evaluated different visualization formats of PRO data, that had been co-designed with patients and healthcare providers within the PRO B study, a large randomized controlled trial investigating alert-based PRO monitoring in patients with metastatic breast cancer. METHODOLOGY: After completion of the PRO B study, patients from both intervention and control group received a paper-based questionnaire together with their individual PRO data report featuring visualizations developed in a preceding design study. Survey items assessed comprehensibility, usefulness, and preferences regarding specific visualization features using Likert scales. Analyses included Mann-Whitney U tests for Likert scale answers, Pearson’s Chi-squared tests for categorical variables and two-sided independent-samples t-tests for numeric variables.

resultsWe collected feedback from 276 participants of the PRO B study. The findings demonstrate a strong overall endorsement on the clarity, emotional appropriateness and usefulness of the suggested graphical displays. Results highlight their potential for enhancing patient empowerment through improved self-awareness and better patient-provider communication.

conclusionsThe positive feedback from PRO B study participants validate the suggested design concepts of PRO data and underscores their valuable role in making these outcomes more accessible, meaningful, and actionable for patients. These data provide the base for developing more flexible, interactive digital tools for routine care.

trial registrationDRKS00024015 Registered 15.02.2021 https://drks.de/search/de/trial/DRKS00024015/details .

Indexed as

Breast NeoplasmsCommunicationPatient Reported Outcome MeasuresAdultAgedFemaleHumansInfographics as TopicMiddle AgedSurveys and QuestionnairesBreast cancerData visualizationDesign concept evaluationHealth communicationHealth literacyPatient-centered carePatient-reported outcomesQualitative data

Identifiers

PMID41422188
PMCPMC12830510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.